INFLAMMATION AND BIOMARKERS
Hospital Nacional de Parapléjicos
Toledo, EspañaPublications in collaboration with researchers from Hospital Nacional de Parapléjicos (1)
2020
-
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients
Brain : a journal of neurology, Vol. 143, Núm. 5, pp. 1414-1430